- Home
- EURK vs CTXR Comparison
EURK vs CTXR Comparison
Compare EURK & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EURK
- CTXR
- Stock Information
- Founded
- EURK 2023
- CTXR 2007
- Country
- EURK Hong Kong
- CTXR United States
- Employees
- EURK N/A
- CTXR N/A
- Industry
- EURK
- CTXR Biotechnology: Pharmaceutical Preparations
- Sector
- EURK
- CTXR Health Care
- Exchange
- EURK NYSE
- CTXR Nasdaq
- Market Cap
- EURK 77.6M
- CTXR 28.4M
- IPO Year
- EURK 2024
- CTXR N/A
- Fundamental
- Price
- EURK $10.16
- CTXR $3.85
- Analyst Decision
- EURK
- CTXR Strong Buy
- Analyst Count
- EURK 0
- CTXR 2
- Target Price
- EURK N/A
- CTXR $54.50
- AVG Volume (30 Days)
- EURK 38.7K
- CTXR 179.9K
- Earning Date
- EURK 01-01-0001
- CTXR 12-27-2024
- Dividend Yield
- EURK N/A
- CTXR N/A
- EPS Growth
- EURK N/A
- CTXR N/A
- EPS
- EURK 0.18
- CTXR N/A
- Revenue
- EURK N/A
- CTXR N/A
- Revenue This Year
- EURK N/A
- CTXR N/A
- Revenue Next Year
- EURK N/A
- CTXR $237.08
- P/E Ratio
- EURK $55.09
- CTXR N/A
- Revenue Growth
- EURK N/A
- CTXR N/A
- 52 Week Low
- EURK $10.03
- CTXR $2.44
- 52 Week High
- EURK $10.16
- CTXR $26.75
- Technical
- Relative Strength Index (RSI)
- EURK N/A
- CTXR 53.94
- Support Level
- EURK N/A
- CTXR $3.15
- Resistance Level
- EURK N/A
- CTXR $5.95
- Average True Range (ATR)
- EURK 0.00
- CTXR 0.51
- MACD
- EURK 0.00
- CTXR 0.37
- Stochastic Oscillator
- EURK 0.00
- CTXR 52.99
About EURK EUREKA ACQUISITION CORP
Eureka Acquisition Corp is a newly incorporated blank check company.
About CTXR Citius Pharmaceuticals Inc.
Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. It is currently advancing four proprietary product candidates: LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma . Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory distress syndrome.